Method of treating fibrotic disorders
US5312621A · kind A · utility
3Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 1992 |
| Grant date | May 17, 1994 |
| Priority date | — |
| Expiry date | Apr 20, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/212
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel method of treating fibrotic disorders in humans comprises the administration of a sufficient quantity of a composition containing a human alpha- or beta-interferon to raise the total concentration of such interferon in the affected tissue area to about 10 to about 4.times.10.sup.7 IU per cubic centimeter. The interferons used can be naturally derived or recombinant DNA-derived. The interferon composition can be administered by any indicated conventional method and can include any pharmaceutically acceptable, interferon-compatible vehicle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.